The CRISPR–Cas system forms the basis of therapeutic gene editing, whereby a guide RNA directs a DNA-cutting enzyme to a targeted gene — usually a mutated one that produces a disease-causing protein.

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

In the decade since the publication of CRISPR-Cas9 as a genome editing technology, the CRISPR toolbox and its applications have profoundly changed biological research, enabling advances through ...

CRISPR excites ambition. Just consider a few CRISPR applications: gene drives (showing promise as a way to prevent malaria); ex vivo and in vivo gene therapies (entering clinical trials); and ...

Over the last decade, RNAi-based loss-of-function screens have proven to be an effective tool to identify essential genes and critical genetic drivers for a host of responses as well as potential drug ...

Benson Hill’s world-class scientists discover new mechanism for CRISPR technology that detects RNA ST. LOUIS--(BUSINESS WIRE)--A groundbreaking research study by a team that included scientists from ...

**ECCMID has now changed its name to ESCMID Global, please credit ESCMID Global Congress (formerly ECCMID, Barcelona, Spain, 27-30 April) in all future stories** Antimicrobial resistance (AMR) is ...

Scientists in China have used Crispr gene editing to restore vision in blind mice, according to research published Friday in the Journal of Experimental Medicine, another advance that signals ...

DUBLIN--(BUSINESS WIRE)--ERS Genomics Limited (‘ERS’) is pleased to announce ATLATL Innovation Centre (‘ATLATL’) as its non-exclusive agent for licensing ERS’ intellectual property for commercial ...